Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0UM7O
|
|||
| Former ID |
DAP001148
|
|||
| Drug Name |
Ketamine
|
|||
| Synonyms |
Calypsol; Cetamina; Green; Ketaject; Ketalar; Ketaminum; Ketanest; Ketoject; Ketolar; Tekam; KETAMINE HCL; Ketalar base; Ketamine Base; Special K; Special K [street name]; CLSTA 20; T385; Cetamina [INN-Spanish]; Dl-Ketamine; Ketalar (TN); Ketamine (INN); Ketamine [INN:BAN]; Ketaminum [INN-Latin]; Ketanest (TN); Ketaset (TN); Tekam (TN); Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-(9CI); Cyclohexanone, 2-(2-chlorophenyl)-2-(methylamino)-, (+-)-(9CI); Cyclohexanone, 2-(o-chlorophenyl)-2-(methylamino)-, (+/-)-(8CI); (+/-)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone; (+/-)-2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone; 2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone; 2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one; 2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone; 2-(o-Chlorophenyl)-2-(methylamino)-cyclohexanone; 2-(o-Chlorophenyl)-2-(methylamino)cyclohexanone
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Anaesthesia [ICD-11: 9A78.6; ICD-9: 338] | Approved | [1], [2] | |
| Therapeutic Class |
Analgesics
|
|||
| Company |
Pfizer Pharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H16ClNO
|
|||
| Canonical SMILES |
CNC1(CCCCC1=O)C2=CC=CC=C2Cl
|
|||
| InChI |
1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3
|
|||
| InChIKey |
YQEZLKZALYSWHR-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 6740-88-1
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
9728, 113688, 841263, 5316929, 7979678, 8152419, 10502126, 11335392, 11360631, 11461603, 15220836, 29215438, 29215439, 29222940, 46508295, 48034987, 48416146, 49958360, 53789372, 56424156, 57322007, 77699966, 96024788, 99233266, 103199488, 103975488, 104222089, 104304622, 105600453, 117480213, 118232324, 124813339, 125683401, 129832339, 134338393, 134987353, 137010368, 142340961, 144205256, 144205257, 160964554, 178101050, 179148642, 216074935, 223837115, 226406322, 250059345
|
|||
| ChEBI ID |
CHEBI:6121
|
|||
| ADReCS Drug ID | BADD_D01228 ; BADD_D01229 | |||
| SuperDrug ATC ID |
N01AX03
|
|||
| SuperDrug CAS ID |
cas=006740881
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [3], [4], [5] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4233). | |||
| REF 2 | Calcium channel blockers in the spectrum of antihypertensive agents. Expert Opin Pharmacother. 2006 Dec;7(17):2385-401. | |||
| REF 3 | Ketamine modulates theta and gamma oscillations. J Cogn Neurosci. 2010 Jul;22(7):1452-64. | |||
| REF 4 | Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. | |||
| REF 5 | Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex. Br J Pharmacol. 1985 Feb;84(2):381-91. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.